NCT03432104View on ClinicalTrials.gov

Evaluation of Bioavailability of Phenolic Compounds From Oxxynea®

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

February 23, 2018

Primary Completion Date

March 7, 2018

Study Completion Date

March 7, 2018

Conditions
Dietary Modification
Interventions
DIETARY_SUPPLEMENT

Oxxynea®

Oxxynea® is a blend of polyphenol-rich extracts from olive, grape, pomegranate, green tea, grapefruit, orange and blueberry. Dosage is 1 x 450 mg-capsule.

DIETARY_SUPPLEMENT

Placebo

Placebo product is 100% maltodextrin. Dosage is 1 x 450 mg-capsule of identical appearance than the verum capsule.

Trial Locations (1)

Unknown

UCAM (Universidad Catolica San Antonio de Murcia), Murcia

All Listed Sponsors
lead

Fytexia

INDUSTRY

NCT03432104 - Evaluation of Bioavailability of Phenolic Compounds From Oxxynea® | Biotech Hunter | Biotech Hunter